Drug Type Small molecule drug |
Synonyms D-F07 |
Target |
Mechanism IRE1 inhibitors(Serine/threonine-protein kinase/endoribonuclease IRE1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H21NO6 |
InChIKeyAPGGXGRMZQTNTP-UHFFFAOYSA-N |
CAS Registry2361297-58-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Burkitt Lymphoma | Preclinical | US | - | |
Chronic Lymphocytic Leukemia | Preclinical | US | - | |
Chronic Lymphocytic Leukemia | Preclinical | US | - |